Trial Profile
The Effect of Acute Statin Treatment on Inflammation and Peripheral Arterial Tone in Patients Undergoing Percutaneous Coronary Intervention.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Coronary artery disease
- Focus Biomarker; Pharmacodynamics
- 07 Nov 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 25 Apr 2011 Status changed from active, no longer recruiting to completed.
- 12 Apr 2011 Actual end date changed from Dec 2009 to Apr 2011 as reported by ClinicalTrials.gov.